Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000912057-18-000249
Filing Date
2018-06-08
Accepted
2018-06-07 20:59:47
Documents
22

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 2259118
2 filename2.htm EX-10.7 146070
3 filename3.htm EX-10.8 110445
4 filename4.htm EX-10.9 177912
5 filename5.htm EX-10.10 77071
6 filename6.htm EX-10.17 47147
7 filename7.htm EX-10.18 48118
8 filename8.htm EX-10.19 22327
9 filename9.htm EX-10.20 177386
10 g65810.jpg GRAPHIC 192634
11 g174308.jpg GRAPHIC 117388
12 g227595.jpg GRAPHIC 28814
13 g240375.jpg GRAPHIC 92066
14 g248225.jpg GRAPHIC 79861
15 g276437.jpg GRAPHIC 41380
16 g334356.jpg GRAPHIC 27649
17 g581875.jpg GRAPHIC 16062
18 g699236.jpg GRAPHIC 128778
19 g928721.jpg GRAPHIC 60863
20 g965634.jpg GRAPHIC 25609
21 g1007614.jpg GRAPHIC 24299
22 g1041457.jpg GRAPHIC 30873
  Complete submission text file 0000912057-18-000249.txt   4261335
Mailing Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017 212-847-9841
Y-mAbs Therapeutics, Inc. (Filer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-01935 | Film No.: 18887933
SIC: 2834 Pharmaceutical Preparations